goda@chem.s.u-tokyo.ac.jp +81-3-5841-4329

Flow cytometry is a powerful tool with applications in diverse fields such as microbiology, immunology, virology, cancer biology, stem cell biology, and metabolic engineering. It rapidly counts and characterizes large heterogeneous populations of cells in suspension (e.g., blood cells, stem cells, cancer cells, and microorganisms) and dissociated solid tissues (e.g., lymph nodes, spleen, and solid tumors) with typical throughputs of 1,000 - 100,000 events per second. By measuring cell size, cell granularity, and the expression of cell surface and intracellular molecules, it provides systematic insights into biological processes. Flow cytometers may also include cell sorting capabilities to enable subsequent additional analysis of the sorted sample (e.g., electron microscopy and DNA/RNA sequencing), cloning, and directed evolution. Unfortunately, traditional flow cytometry has several critical limitations as it mainly relies on fluorescent labeling for cellular phenotyping, which is an indirect measure of intracellular molecules and surface antigens. Furthermore, it often requires time-consuming preparation protocols and is incompatible with cell therapy.

To overcome these difficulties, a different type of flow cytometry based on direct measurements of intracellular molecules by Raman spectroscopy, or "Raman flow cytometry" for short, has emerged. Raman flow cytometry obtains a chemical fingerprint of the cell in a nondestructive manner, allowing for single-cell metabolic phenotyping. However, its slow signal acquisition due to the weak light–molecule interaction of spontaneous Raman scattering prevents the throughput necessary to interrogate large cell populations in reasonable time frames, resulting in throughputs of a few events per second.

Recently, we have provided a remedy to this throughput limit by integrating coherent Raman scattering methods such as stimulated Raman scattering (SRS) and coherent anti-Stokes Raman scattering (CARS) into flow cytometry. It offers a significantly enhanced light–sample interaction and hences enable high-throughput Raman flow cytometry, Raman imaging flow cytometry, and even Raman image-activated cell sorting (RIACS). Currently, we work on the further improvement of coherent Raman flow cytometry and the exploitation of new applications that have not been possible with conventional fluorescence-based flow cytometry or spontaneous Raman flow cytometry. Coherent Raman flow cytometry offers emerging opportunities in a wide range of fields from microbiology to cell therapy and cancer detection.


References


Raman flow cytometry

  • Field leader: Kotaro Hiramatsu
  • Funding: KISTEC, Nakatani Foundation, Ogasawara Foundation
  • Collaboration: Serendipity Lab